Singclean: Unveiled Singfiller® and Singderm® in IMCAS ASIA 2024, Poised for Thailand's Big Launch

June 25, 2024 04:00 AM BST | By Cision
Follow us on Google News: https://kalkinemedia.com/resources/assets/public/images/google-news.webp
 Singclean: Unveiled Singfiller® and Singderm® in IMCAS ASIA 2024, Poised for Thailand's Big Launch
Image source: Kalkine Media

BANGKOK, June 25, 2024 /PRNewswire/ -- Singclean, a global player and a leading Chinese manufacturer of high-quality medical aesthetic products, was excited to announce in IMCAS Asia that Singfiller® and Singderm® HA fillers will launch in Thailand this November. Although still not officially certified in Thailand, Singfiller® and Singderm®'s global excellent performance and good reputation have sparked interest among local agents and doctors, who eagerly await their introduction to bring new vitality and choices to Thailand's medical aesthetics field.

 
IMCAS Asia 2024 - Academic Lecture of Singclean

Dr. Chen Li, a renowned Chinese plastic surgeon, presented an amazing symposium "Exploration on the Clinical Application of Layered Anti-aging and Comprehensive Facial Rejuvenation" combined with cutting-edge anti-aging technology of Singfiller® and Singderm® onsite.

Figure 1: Dr.Chen Li , Chinese renowned plastic surgeon
Figure 1: Dr.Chen Li , Chinese renowned plastic surgeon

He pointed out, "dermal fillers with different particle sizes and elasticity should be injected into different skin levels, which is the concept of layered anti-aging." His lecture, centering on choosing right filler for injection site offered a captivating exploration of medical aesthetics to experts, scholars, and industry professionals present by perfectly integrating aesthetic principles with injection techniques.

Figure 2: Singfiller & Singderm launch in Thailand
Figure 2: Singfiller & Singderm launch in Thailand

Singfiller®, biphasic dermal filler, has five specifications with different particle sizes. Small particles type is injected into dermis for improving superficial wrinkles. Medium particles type is injected into middle and deep dermis, superficial fat and deep fat compartments for improving moderate facial wrinkles. Large particles type is injected into periosteum layer for deep soft tissue filling and contour shaping.

Singderm®, monophasic dermal filler with superior viscosity, cohesivity and elasticity is ideal for deep layer filling, both for volume adding and face sculpting, and thus making it a universal filler.

Both Singfiller® and Singderm® have achieved full coverage in all provinces in China and are popular in over 30 countries and regions including Southeast Asia, Europe, Middle East, and South America.

Valued at USD 1.46 billion in 2023, the Thai aesthetic medicine market is characterized by substantial demand. However, at the same time, competition is fierce. Singclean embraces the philosophy that "competition breeds champion". By cooperating with local partners, Singclean is committed to enhancing injection training, after-sales service and continuously offering innovative aesthetic solutions to meet customers' demands, like PLLA filler and PDRN skin booster.

Singfiller® and Singderm®'s launch in Thailand will definitely accelerate Singclean's global strategic expansion. Moving forward, Singclean will leverage its strengths in R&D, manufacturing, quality controlling and services to advance the development of global medical aesthetics industry.

Contact:Lydia Liu, Regional Manager
Tel.:+86 13916991572
Email:[email protected]


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Limited, Company No. 12643132 (“Kalkine Media, we or us”) and is available for personal and non-commercial use only. Kalkine Media is an appointed representative of Kalkine Limited, who is authorized and regulated by the FCA (FRN: 579414). The non-personalized advice given by Kalkine Media through its Content does not in any way endorse or recommend individuals, investment products or services suitable for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a qualified financial planner and/or adviser. No liability is accepted by Kalkine Media or Kalkine Limited and/or any of its employees/officers, for any investment loss, or any other loss or detriment experienced by you for any investment decision, whether consequent to, or in any way related to this Content, the provision of which is a regulated activity. Kalkine Media does not intend to exclude any liability which is not permitted to be excluded under applicable law or regulation. Some of the Content on this website may be sponsored/non-sponsored, as applicable. However, on the date of publication of any such Content, none of the employees and/or associates of Kalkine Media hold positions in any of the stocks covered by Kalkine Media through its Content. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content. Some of the images/music/video that may be used in the Content are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music or video used in the Content unless stated otherwise. The images/music/video that may be used in the Content are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.

AI on the Rise: A Look at Top AI Companies and Their Stocks

Recent Articles

Investing Tips

Previous Next